Jeppesen D, Zhang Q, Franklin J, Coffey R. Extracellular vesicles and nanoparticles: rising complexities. Tendencies Cell Biol. 2023. https://doi.org/10.1016/j.tcb.2023.01.002.
Van der Heyden A, Chanthavong P, Angles-Cano E, Bonnet H, Dejeu J, Cras A, et al. Grafted dinuclear zinc complexes for selective recognition of phosphatidylserine: software to the seize of extracellular membrane microvesicles. J Inorg Biochem. 2023;239:112065.
Han Q-F, Li W-J, Hu Ok-S, Gao J, Zhai W-L, Yang J-H, et al. Exosome biogenesis: equipment, regulation, and therapeutic implications in most cancers. Mol Most cancers. 2022;21:207.
Zhou M, Li Y-J, Tang Y-C, Hao X-Y, Xu W-J, Xiang D-X, et al. Apoptotic our bodies for superior drug supply and remedy. J Managed Launch. 2022;351:394–406.
Zhang H, Freitas D, Kim HS, Fabijanic Ok, Li Z, Chen H, et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by uneven movement field-flow fractionation. Nat Cell Biol. 2018;20:332–43.
Anand S, Samuel M, Mathivanan S, Exomeres. A New Member of Extracellular Vesicles Household. Subcell Biochem. 2021;97:89–97.
Zhang Q, Jeppesen DK, Higginbotham JN, Graves-Deal R, Trinh VQ, Ramirez MA, et al. Supermeres are practical extracellular nanoparticles replete with illness biomarkers and therapeutic targets. Nat Cell Biol. 2021;23:1240–54.
Li X, Corbett AL, Taatizadeh E, Tasnim N, Little JP, Garnis C, et al. Challenges and alternatives in exosome research-perspectives from biology, engineering, and most cancers remedy. APL Bioeng. 2019;3:011503.
Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Tendencies Cell Biol. 2015;25:364–72.
Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal info for research of extracellular vesicles 2018 (MISEV2018): a place assertion of the Worldwide Society for Extracellular vesicles and replace of the MISEV2014 pointers. J Extracell Vesicles. 2018;7:1535750.
Jeppesen D, Fenix A, Franklin J, Higginbotham J, Zhang Q, Zimmerman L, et al. Reassessment of Exosome Composition. Cell. 2019;177:428–45e18.
Kalluri R, LeBleu VS. The biology, perform, and biomedical functions of exosomes. Science. 2020;367:eaau6977.
Mulcahy LA, Pink RC, Carter DRF. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3:24641.
Isaac R, Reis F, Ying W, Olefsky J. Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metab. 2021;33:1744–62.
Tkach M, Théry C. Communication by Extracellular vesicles: the place we’re and the place we have to go. Cell. 2016;164:1226–32.
Pluchino S, Smith J. Explicating Exosomes: reclassifying the rising stars of Intercellular Communication. Cell. 2019;177:225–7.
Plikus M, Wang X, Sinha S, Forte E, Thompson S, Herzog E, et al. Fibroblasts: Origins, definitions, and features in well being and illness. Cell. 2021;184:3852–72.
Moretti L, Stalfort J, Barker TH, Abebayehu D. The interaction of fibroblasts, the extracellular matrix, and irritation in scar formation. J Biol Chem. 2022;298:101530.
Xue D, Tabib T, Morse C, Yang Y, Domsic RT, Khanna D, et al. Growth of Fcγ receptor IIIa-Constructive macrophages, ficolin 1-Constructive monocyte-derived dendritic cells, and Plasmacytoid dendritic cells Related to extreme pores and skin illness in systemic sclerosis. Arthritis Rheumatol. 2022;74:329–41.
Zhao M, Wang L, Wang M, Zhou S, Lu Y, Cui H, et al. Focusing on fibrosis, mechanisms and cilinical trials. Sign Transduct Goal Ther. 2022;7:206.
Rockey DC, Bell PD, Hill JA. Fibrosis–a typical pathway to organ harm and failure. N Engl J Med. 2015;372:1138–49.
Lo Cicero A, Stahl PD, Raposo G. Extracellular vesicles shuffling intercellular messages: for good or for dangerous. Curr Opin Cell Biol. 2015;35:69–77.
Krenkel O, Hundertmark J, Ritz TP, Weiskirchen R, Tacke F. Single cell RNA sequencing identifies subsets of hepatic stellate cells and Myofibroblasts in Liver Fibrosis. Cells. 2019;8:503.
Habermann AC, Gutierrez AJ, Bui LT, Yahn SL, Winters NI, Calvi CL, et al. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. Sci Adv. 2020;6:eaba1972.
Rao M, Wang X, Guo G, Wang L, Chen S, Yin P, et al. Resolving the intertwining of irritation and fibrosis in human coronary heart failure at single-cell stage. Primary Res Cardiol. 2021;116:55.
Wang FD, Zhou J, Chen EQ. Molecular mechanisms and potential new therapeutic medicine for liver fibrosis. Entrance Pharmacol. 2022;13:787748.
Gu H, Yang Ok, Shen Z, Jia Ok, Liu P, Pan M, et al. ER stress-induced adipocytes secrete-aldo-keto reductase 1B7-containing exosomes that trigger nonalcoholic steatohepatitis in mice. Free Radical Biol Med. 2021;163:220–33.
Hirsova P, Ibrahim SH, Krishnan A, Verma VK, Bronk SF, Werneburg NW, et al. Lipid-Induced Signaling causes launch of inflammatory extracellular vesicles from hepatocytes. Gastroenterology. 2016;150:956–67.
Search engine optimisation W, Eun HS, Kim SY, Yi HS, Lee YS, Park SH, et al. Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 manufacturing by γδ T cells in liver fibrosis. Hepatology. 2016;64:616–31.
Eguchi A, Yan R, Pan SQ, Wu R, Kim J, Chen Y, et al. Complete characterization of hepatocyte-derived extracellular vesicles identifies direct miRNA-based regulation of hepatic stellate cells and DAMP-based hepatic macrophage IL-1β and IL-17 upregulation in alcoholic hepatitis mice. J Mol Med (Berl). 2020;98:1021–34.
Liu X, Tan S, Liu H, Jiang J, Wang X, Li L, et al. Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to advertise liver fibrosis. Hepatology. 2022. https://doi.org/10.1002/hep.32662.
Gao H, Jin Z, Bandyopadhyay G, Wang G, Zhang D, Rocha Ok, et al. Aberrant iron distribution by way of hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis. Cell Metab. 2022;34:1201–13e5.
Zhang X, Zeng Y, Zhao L, Xu Q, Miao D, Yu F. Focusing on Hepatic Stellate Cell Dying to Reverse Hepatic Fibrosis. Present drug targets. 2023. https://doi.org/10.2174/1389450124666230330135834.
Chen L, Yao X, Yao H, Ji Q, Ding G, Liu X. Exosomal mir-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells. Faseb j. 2020;34:5178–92.
Gao J, Wei B, de Assuncao TM, Liu Z, Hu X, Ibrahim S, et al. Hepatic stellate cell autophagy inhibits extracellular vesicle launch to attenuate liver fibrosis. J Hepatol. 2020;73:1144–54.
Kostallari E, Hirsova P, Prasnicka A, Verma VK, Yaqoob U, Wongjarupong N, et al. Hepatic stellate cell-derived platelet-derived development issue receptor-alpha-enriched extracellular vesicles promote liver fibrosis in mice by SHP2. Hepatology. 2018;68:333–48.
Wan L, Xia T, Du Y, Liu J, Xie Y, Zhang Y, et al. Exosomes from activated hepatic stellate cells comprise GLUT1 and PKM2: a task for exosomes in metabolic swap of liver nonparenchymal cells. Faseb j. 2019;33:8530–42.
Li X, Liu R, Huang Z, Gurley E, Wang X, Wang J, et al. Cholangiocyte-derived exosomal lengthy noncoding RNA H19 promotes cholestatic liver harm in mouse and people. Hepatology. 2018;68:599–615.
Liu R, Li X, Zhu W, Wang Y, Zhao D, Wang X, et al. Cholangiocyte-derived Exosomal Lengthy Noncoding RNA H19 promotes hepatic stellate cell activation and Cholestatic Liver Fibrosis. Hepatology. 2019;70:1317–35.
Li X, Liu R, Wang Y, Zhu W, Zhao D, Wang X et al. Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Irritation beneath Cholestatic Circumstances. Cells. 2020; 9.
Xiao Y, Liu R, Li X, Gurley EC, Hylemon PB, Lu Y, et al. Lengthy noncoding RNA H19 contributes to Cholangiocyte Proliferation and Cholestatic Liver fibrosis in biliary atresia. Hepatology. 2019;70:1658–73.
Montaldo C, Terri M, Riccioni V, Battistelli C, Bordoni V, D’Offizi G, et al. Fibrogenic alerts persist in DAA-treated HCV sufferers after sustained virological response. J Hepatol. 2021;75:1301–11.
Welsh JA, Scorletti E, Clough GF, Englyst NA, Byrne CD. Leukocyte extracellular vesicle focus is inversely related to liver fibrosis severity in NAFLD. J Leukoc Biol. 2018;104:631–9.
Payancé A, Silva-Junior G, Bissonnette J, Tanguy M, Pasquet B, Levi C, et al. Hepatocyte microvesicle ranges enhance prediction of mortality in sufferers with cirrhosis. Hepatology. 2018;68:1508–18.
Weil D, Di Martino V, Mourey G, Biichle S, Renaudin A, Laheurte C, et al. Small annexin V-Constructive platelet-derived microvesicles have an effect on prognosis in cirrhosis: a longitudinal research. Clin Transl Gastroenterol. 2021;12:e00333.
Wilson MS, Wynn TA. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol. 2009;2:103–21.
Luppi F, Kalluri M, Faverio P, Kreuter M, Ferrara G. Idiopathic pulmonary fibrosis past the lung: understanding illness mechanisms to enhance analysis and administration. Respir Res. 2021;22:109.
Asghar S, Monkley S, Smith DJF, Hewitt RJ, Grime Ok, Murray LA, et al. Epithelial senescence in idiopathic pulmonary fibrosis is propagated by small extracellular vesicles. Respir Res. 2023;24:51.
Xie H, Gao YM, Zhang YC, Jia MW, Peng F, Meng QH, et al. Low let-7d exosomes from pulmonary vascular endothelial cells drive lung pericyte fibrosis by the TGFβRI/FoxM1/Smad/β-catenin pathway. J Cell Mol Med. 2020;24:13913–26.
Martin-Medina A, Lehmann M, Burgy O, Hermann S, Baarsma HA, Wagner DE, et al. Elevated Extracellular vesicles mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2018;198:1527–38.
Zhu L, Chen Y, Chen M, Wang W. Mechanism of mir-204-5p in exosomes derived from bronchoalveolar lavage fluid on the development of pulmonary fibrosis by way of AP1S2. Ann Transl Med. 2021;9:1068.
Shichino S, Abe J, Ueha S, Otsuji M, Tsukui T, Kosugi-Kanaya M, et al. Decreased provide of monocyte-derived macrophages results in a transition from nodular to diffuse lesions and tissue cell activation in silica-induced pulmonary fibrosis in mice. Am J Pathol. 2015;185:2923–38.
Misharin AV, Morales-Nebreda L, Reyfman PA, Cuda CM, Walter JM, McQuattie-Pimentel AC, et al. Monocyte-derived alveolar macrophages drive lung fibrosis and persist within the lung over the life span. J Exp Med. 2017;214:2387–404.
Yao MY, Zhang WH, Ma WT, Liu QH, Xing LH, Zhao GF. microRNA-328 in exosomes derived from M2 macrophages exerts a promotive impact on the development of pulmonary fibrosis by way of FAM13A in a rat mannequin. Exp Mol Med. 2019;51:1–16.
Qian Q, Ma Q, Wang B, Qian Q, Zhao C, Feng F, et al. Downregulated mir-129-5p expression inhibits rat pulmonary fibrosis by upregulating STAT1 gene expression in macrophages. Int Immunopharmacol. 2022;109:108880.
Guiot J, Cambier M, Boeckx A, Henket M, Nivelles O, Gester F, et al. Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells by supply of antifibrotic miR-142-3p. Thorax. 2020;75:870–81.
Chen L, Yang Y, Yue R, Peng X, Yu H, Huang X. Exosomes derived from hypoxia-induced alveolar epithelial cells stimulate interstitial pulmonary fibrosis by a HOTAIRM1-dependent mechanism. Lab Make investments. 2022;102:935–44.
van de Vlekkert D, Demmers J, Nguyen XX, Campos Y, Machado E, Annunziata I, et al. Extreme exosome launch is the pathogenic pathway linking a lysosomal deficiency to generalized fibrosis. Sci Adv. 2019;5:eaav3270.
Njock M, Guiot J, Henket M, Nivelles O, Thiry M, Dequiedt F, et al. Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis. Thorax. 2019;74:309–12.
d’Alessandro M, Gangi S, Soccio P, Cantó E, Osuna-Gómez R, Bergantini L et al. The Results of Interstitial Lung Illnesses on Alveolar Extracellular Vesicles Profile: A Multicenter Research. Int J Mol Sci. 2023; 24.
Tang R, Hu Y, Mei S, Zhou Y, Feng J, Jin T, et al. Non-coding RNA alterations in extracellular vesicles from bronchoalveolar lavage fluid contribute to mechanical ventilation-induced pulmonary fibrosis. Entrance Immunol. 2023;14:1141761.
Elliot S, Catanuto P, Pereira-Simon S, Xia X, Shahzeidi S, Roberts E et al. Urine-derived exosomes from people with IPF carry pro-fibrotic cargo. Elife. 2022; 11.
Fan Z, Guan J. Antifibrotic therapies to regulate cardiac fibrosis. Biomater Res. 2016;20:13.
Farbehi N, Patrick R, Dorison A, Xaymardan M, Janbandhu V, Wystub-Lis Ok et al. Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in well being and harm. Elife. 2019; 8.
Yang J, Yu X, Xue F, Li Y, Liu W, Zhang S. Exosomes derived from cardiomyocytes promote cardiac fibrosis by way of myocyte-fibroblast cross-talk. Am J Transl Res. 2018;10:4350–66.
Wang X, Morelli MB, Matarese A, Sardu C, Santulli G. Cardiomyocyte-derived exosomal microRNA-92a mediates post-ischemic myofibroblast activation each in vitro and ex vivo. ESC Coronary heart Fail. 2020;7:284–8.
Li J, Salvador AM, Li G, Valkov N, Ziegler O, Yeri A, et al. Mir-30d regulates Cardiac Transforming by Intracellular and Paracrine Signaling. Circ Res. 2021;128:e1–e23.
Cai L, Chao G, Li W, Zhu J, Li F, Qi B, et al. Activated CD4(+) T cells-derived exosomal mir-142-3p boosts post-ischemic ventricular transforming by activating myofibroblast. Growing old. 2020;12:7380–96.
Wang Y, Li C, Zhao R, Qiu Z, Shen C, Wang Z, et al. CircUbe3a from M2 macrophage-derived small extracellular vesicles mediates myocardial fibrosis after acute myocardial infarction. Theranostics. 2021;11:6315–33.
Shaihov-Teper O, Ram E, Ballan N, Brzezinski R, Naftali-Shani N, Masoud R, et al. Extracellular vesicles from Epicardial Fats facilitate Atrial Fibrillation. Circulation. 2021;143:2475–93.
Peng M, Solar R, Hong Y, Wang J, Xie Y, Zhang X, et al. Extracellular vesicles carrying proinflammatory components could unfold atherosclerosis to distant areas. Cell Mol Life Sci. 2022;79:430.
Fandl HK, Garcia VP, Treuth JW, Brewster LM, Greiner JJ, Davy KP, et al. Endothelial derived extracellular vesicles from overweight/hypertensive adults enhance components related to hypertrophy and fibrosis in cardiomyocytes. Am J Physiol Coronary heart Circ Physiol. 2023. https://doi.org/10.1152/ajpheart.00035.2023.
Olson EN. MicroRNAs as therapeutic targets and biomarkers of heart problems. Sci Transl Med. 2014;6:239ps3.
Fan J, Ren M, He Y. Diagnostic and Therapeutic Properties of Exosomes in Cardiac Fibrosis. Entrance Cell Dev Biol. 2022;10:931082.
Wang L, Liu J, Xu B, Liu YL, Liu Z. Decreased exosome miR-425 and miR-744 within the plasma represents the development of fibrosis and coronary heart failure. Kaohsiung J Med Sci. 2018;34:626–33.
Liu Y, Li Q, Hosen MR, Zietzer A, Flender A, Levermann P, et al. Atherosclerotic situations promote the packaging of practical MicroRNA-92a-3p into endothelial microvesicles. Circ Res. 2019;124:575–87.
Chen Y, Chen X, Li H, Li Y, Cheng D, Tang Y, et al. Serum extracellular vesicles containing MIAT induces atrial fibrosis, irritation and oxidative stress to advertise atrial transforming and atrial fibrillation by way of blockade of miR-485-5p-mediated CXCL10 inhibition. Clin Transl Med. 2021;11:e482.
Yang J, Yu XF, Li YY, Xue FT, Zhang S. Decreased HSP70 expression on serum exosomes contributes to cardiac fibrosis throughout senescence. Eur Rev Med Pharmacol Sci. 2019;23:3993–4001.
Yu SM, Bonventre JV. Acute kidney harm and maladaptive tubular restore resulting in renal fibrosis. Curr Opin Nephrol Hypertens. 2020;29:310–8.
Jing H, Tang S, Lin S, Liao M, Chen H, Zhou J. The function of extracellular vesicles in renal fibrosis. Cell Dying Dis. 2019;10:367.
Kosanović M, Llorente A, Glamočlija S, Valdivielso JM, Bozic M. Extracellular Vesicles and Renal Fibrosis: An Odyssey towards a New Therapeutic Method. Int J Mol Sci. 2021; 22.
Wu XM, Gao YB, Cui FQ, Zhang N. Exosomes from excessive glucose-treated glomerular endothelial cells activate mesangial cells to advertise renal fibrosis. Biol Open. 2016;5:484–91.
Wu X, Gao Y, Xu L, Dang W, Yan H, Zou D, et al. Exosomes from excessive glucose-treated glomerular endothelial cells set off the epithelial-mesenchymal transition and dysfunction of podocytes. Sci Rep. 2017;7:9371.
Ling L, Tan Z, Zhang C, Gui S, Cui Y, Hu Y, et al. CircRNAs in exosomes from excessive glucose-treated glomerular endothelial cells activate mesangial cells. Am J Transl Res. 2019;11:4667–82.
Bai S, Xiong X, Tang B, Ji T, Li X, Qu X, et al. Exosomal circ_DLGAP4 promotes diabetic kidney illness development by sponging miR-143 and concentrating on ERBB3/NF-κB/MMP-2 axis. Cell Dying Dis. 2020;11:1008.
Zhu Y, Zha F, Tang B, Ji TT, Li XY, Feng L, et al. Exosomal hsa_circ_0125310 promotes cell proliferation and fibrosis in diabetic nephropathy by way of sponging miR-422a and concentrating on the IGF1R/p38 axis. J Cell Mol Med. 2022;26:151–62.
Munkonda MN, Akbari S, Landry C, Solar S, Xiao F, Turner M, et al. Podocyte-derived microparticles promote proximal tubule fibrotic signaling by way of p38 MAPK and CD36. J Extracell Vesicles. 2018;7:1432206.
Su H, Qiao J, Hu J, Li Y, Lin J, Yu Q, et al. Podocyte-derived extracellular vesicles mediate renal proximal tubule cells dedifferentiation by way of microRNA-221 in diabetic nephropathy. Mol Cell Endocrinol. 2020;518:111034.
Jeon JS, Kim E, Bae YU, Yang WM, Lee H, Kim H et al. microRNA in Extracellular Vesicles Launched by Broken Podocytes Promote Apoptosis of Renal Tubular Epithelial Cells. Cells. 2020; 9.
Liu X, Miao J, Wang C, Zhou S, Chen S, Ren Q, et al. Tubule-derived exosomes play a central function in fibroblast activation and kidney fibrosis. Kidney Int. 2020;97:1181–95.
Liu D, Liu F, Li Z, Pan S, Xie J, Zhao Z, et al. HNRNPA1-mediated exosomal sorting of mir-483-5p out of renal tubular epithelial cells promotes the development of diabetic nephropathy-induced renal interstitial fibrosis. Cell Dying Dis. 2021;12:255.
Zheng SB, Zheng Y, Jin LW, Zhou ZH, Li ZY. Microvesicles containing microRNA-21 secreted by proximal tubular epithelial cells are concerned in renal interstitial fibrosis by activating AKT pathway. Eur Rev Med Pharmacol Sci. 2018;22:707–14.
Qu NY, Zhang ZH, Zhang XX, Xie WW, Niu XQ. Microvesicles containing microRNA-216a secreted by tubular epithelial cells take part in renal interstitial fibrosis by activating PTEN/AKT pathway. Eur Rev Med Pharmacol Sci. 2019;23:6629–36.
Jia Y, Zheng Z, Guan M, Zhang Q, Li Y, Wang L, et al. Exendin-4 ameliorates excessive glucose-induced fibrosis by inhibiting the secretion of miR-192 from injured renal tubular epithelial cells. Exp Mol Med. 2018;50:1–13.
Lv LL, Feng Y, Wen Y, Wu WJ, Ni HF, Li ZL, et al. Exosomal CCL2 from tubular epithelial cells is crucial for Albumin-Induced Tubulointerstitial irritation. J Am Soc Nephrol. 2018;29:919–35.
Jia Y, Zheng Z, Xue M, Zhang S, Hu F, Li Y, et al. Extracellular vesicles from Albumin-Induced tubular epithelial cells promote the M1 macrophage phenotype by Focusing on Klotho. Mol remedy: J Am Soc Gene Remedy. 2019;27:1452–66.
Lv LL, Feng Y, Wu M, Wang B, Li ZL, Zhong X, et al. Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney harm. Cell Dying Differ. 2020;27:210–26.
Zhao S, Li W, Yu W, Rao T, Li H, Ruan Y, et al. Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts by way of concentrating on PTEN in obstructed kidneys. Theranostics. 2021;11:8660–73.
Zhou X, Zhao S, Li W, Ruan Y, Yuan R, Ning J, et al. Tubular cell-derived exosomal mir-150-5p contributes to renal fibrosis following unilateral ischemia-reperfusion harm by activating fibroblast in vitro and in vivo. Int J Biol Sci. 2021;17:4021–33.
Chen S, Zhang M, Li J, Huang J, Zhou S, Hou X, et al. β-catenin-controlled tubular cell-derived exosomes play a key function in fibroblast activation by way of the OPN-CD44 axis. J Extracell Vesicles. 2022;11:e12203.
Hu R, Li X, Peng C, Gao R, Ma L, Hu J et al. miR-196b-5p-enriched extracellular vesicles from tubular epithelial cells mediated aldosterone-induced renal fibrosis in mice with diabetes. BMJ Open Diabetes Res Care. 2020; 8.
Ranches G, Zeidler M, Kessler R, Hoelzl M, Hess MW, Vosper J, et al. Exosomal mitochondrial tRNAs and miRNAs as potential predictors of irritation in renal proximal tubular epithelial cells. Mol Ther Nucleic Acids. 2022;28:794–813.
Petzuch B, Bénardeau A, Hofmeister L, Meyer J, Hartmann E, Pavkovic M, et al. Urinary miRNA profiles in persistent kidney Damage-Advantages of Extracellular Vesicle Enrichment and miRNAs as potential biomarkers for renal fibrosis, glomerular Damage, and endothelial dysfunction. Toxicol Sci. 2022;187:35–50.
Cao Y, Shi Y, Yang Y, Wu Z, Peng N, Xiao J, et al. Urinary exosomes derived circRNAs as biomarkers for persistent renal fibrosis. Ann Med. 2022;54:1966–76.
Cao Y, Shi Y, Wang Y, Yang Y, Guo W, Zhang C et al. Exosomal hsa_circ_0008925 from Urine Is Associated to Continual Renal Fibrosis. Dis Markers. 2022; 2022:1899282.
Martín-Taboada M, Corrales P, Medina-Gómez G, Vila-Bedmar R. Tackling the consequences of extracellular vesicles in fibrosis. Eur J Cell Biol. 2022;101:151221.
Henderson NC, Rieder F, Wynn TA. Fibrosis: from mechanisms to medicines. Nature. 2020;587:555–66.
Distler JHW, Györfi AH, Ramanujam M, Whitfield ML, Königshoff M, Lafyatis R. Shared and distinct mechanisms of fibrosis. Nat Rev Rheumatol. 2019;15:705–30.
Friedman SL, Pinzani M. Hepatic fibrosis 2022: unmet wants and a blueprint for the long run. Hepatology. 2022;75:473–88.
Perelas A, Silver RM, Arrossi AV, Highland KB. Systemic sclerosis-associated interstitial lung illness. Lancet Respir Med. 2020;8:304–20.
Hass R, Kasper C, Böhm S, Jacobs R. Totally different populations and sources of human mesenchymal stem cells (MSC): a comparability of grownup and neonatal tissue-derived MSC. Cell Commun Sign. 2011;9:12.
Li H, Zhang B, Lu Y, Jorgensen M, Petersen B, Music S. Adipose tissue-derived mesenchymal stem cell-based liver gene supply. J Hepatol. 2011;54:930–8.
Kim S, Lee S, Lim J, Choi H, Kang H, Jeon N, et al. Human bone marrow-derived mesenchymal stem cells play a task as a vascular pericyte within the reconstruction of human BBB on the angiogenesis microfluidic chip. Biomaterials. 2021;279:121210.
Li CD, Zhang WY, Li HL, Jiang XX, Zhang Y, Tang PH, et al. Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical twine blood lymphocyte proliferation. Cell Res. 2005;15:539–47.
Li M, Soder R, Abhyankar S, Abdelhakim H, Braun MW, Trinidad CV, et al. WJMSC-derived small extracellular vesicle improve T cell suppression by PD-L1. J Extracell Vesicles. 2021;10:e12067.
Krampera M, Le Blanc Ok. Mesenchymal stromal cells: putative microenvironmental modulators grow to be cell remedy. Cell Stem Cell. 2021;28:1708–25.
Tieu A, Lalu M, Slobodian M, Gnyra C, Fergusson D, Montroy J, et al. An evaluation of mesenchymal stem cell-derived extracellular vesicles for preclinical use. ACS Nano. 2020;14:9728–43.
Bray ER, Kirsner RS, Badiavas EV. Mesenchymal stem cell-derived extracellular vesicles as an Superior Remedy for Continual Wounds. Chilly Spring Harbor Perspect Biol. 2022;14:a041227.
Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, et al. Exosomes derived from human umbilical twine mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 2013;22:845–54.
Lai P, Chen X, Guo L, Wang Y, Liu X, Liu Y, et al. A potent immunomodulatory function of exosomes derived from mesenchymal stromal cells in stopping cGVHD. J Hematol Oncol. 2018;11:135.
Willis GR, Fernandez-Gonzalez A, Anastas J, Vitali SH, Liu X, Ericsson M, et al. Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung perform by Macrophage Immunomodulation. Am J Respir Crit Care Med. 2018;197:104–16.
Willis GR, Fernandez-Gonzalez A, Reis M, Yeung V, Liu X, Ericsson M, et al. Mesenchymal stromal cell-derived small extracellular vesicles restore lung structure and enhance train capability in a mannequin of neonatal hyperoxia-induced lung harm. J Extracell Vesicles. 2020;9:1790874.
Bier A, Berenstein P, Kronfeld N, Morgoulis D, Ziv-Av A, Goldstein H, et al. Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic results in Duchenne muscular dystrophy. Biomaterials. 2018;174:67–78.
Hu X, Shen N, Liu A, Wang W, Zhang L, Sui Z, et al. Bone marrow mesenchymal stem cell-derived exosomal miR-34c-5p ameliorates RIF by inhibiting the core fucosylation of a number of proteins. Mol Ther. 2022;30:763–81.
Ji C, Zhang J, Zhu Y, Shi H, Yin S, Solar F, et al. Exosomes derived from hucMSC attenuate renal fibrosis by CK1δ/β-TRCP-mediated YAP degradation. Cell Dying Dis. 2020;11:327.
Shi Z, Wang Q, Zhang Y, Jiang D. Extracellular vesicles produced by bone marrow mesenchymal stem cells attenuate renal fibrosis, partially by inhibiting the RhoA/ROCK pathway, in a UUO rat mannequin. Stem Cell Res Ther. 2020;11:253.
Marbán E, Liao Ok. On the mobile origin of cardiosphere-derived cells (CDCs). Primary Res Cardiol. 2022;117:12.
Grigorian-Shamagian L, Liu W, Fereydooni S, Middleton RC, Valle J, Cho JH, et al. Cardiac and systemic rejuvenation after cardiosphere-derived cell remedy in senescent rats. Eur Coronary heart J. 2017;38:2957–67.
Hirai Ok, Ousaka D, Fukushima Y, Kondo M, Eitoku T, Shigemitsu Y et al. Cardiosphere-derived exosomal microRNAs for myocardial restore in pediatric dilated cardiomyopathy. Sci Transl Med. 2020; 12.
Lin YN, Mesquita T, Sanchez L, Chen YH, Liu W, Li C, et al. Extracellular vesicles from immortalized cardiosphere-derived cells attenuate arrhythmogenic cardiomyopathy in desmoglein-2 mutant mice. Eur Coronary heart J. 2021;42:3558–71.
Gallet R, Dawkins J, Valle J, Simsolo E, de Couto G, Middleton R, et al. Exosomes secreted by cardiosphere-derived cells scale back scarring, attenuate adversarial remodelling, and enhance perform in acute and persistent porcine myocardial infarction. Eur Coronary heart J. 2017;38:201–11.
Dawkins JF, Ehdaie A, Rogers R, Soetkamp D, Valle J, Holm Ok, et al. Organic substrate modification suppresses ventricular arrhythmias in a porcine mannequin of persistent ischaemic cardiomyopathy. Eur Coronary heart J. 2022;43:2139–56.
Tseliou E, Fouad J, Reich H, Slipczuk L, de Couto G, Aminzadeh M, et al. Fibroblasts rendered Antifibrotic, Antiapoptotic, and angiogenic by priming with Cardiosphere-Derived Extracellular membrane vesicles. J Am Coll Cardiol. 2015;66:599–611.
Ishigami S, Ohtsuki S, Eitoku T, Ousaka D, Kondo M, Kurita Y, et al. Intracoronary Cardiac Progenitor cells in single ventricle physiology: the PERSEUS (Cardiac Progenitor Cell infusion to deal with Univentricular Coronary heart Illness) Randomized Section 2 Trial. Circ Res. 2017;120:1162–73.
Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Deregibus MC, et al. Isolation and characterization of a stem cell inhabitants from grownup human liver. Stem Cells. 2006;24:2840–50.
Bruno S, Pasquino C, Herrera Sanchez MB, Tapparo M, Figliolini F, Grange C, et al. HLSC-Derived extracellular vesicles attenuate liver fibrosis and irritation in a murine mannequin of non-alcoholic steatohepatitis. Mol Ther. 2020;28:479–89.
Dinh PC, Cores J, Hensley MT, Vandergriff AC, Tang J, Allen TA, et al. Derivation of therapeutic lung spheroid cells from minimally invasive transbronchial pulmonary biopsies. Respir Res. 2017;18:132.
Henry E, Cores J, Hensley MT, Anthony S, Vandergriff A, de Andrade JB, et al. Grownup lung spheroid cells comprise progenitor cells and mediate regeneration in rodents with Bleomycin-Induced Pulmonary Fibrosis. Stem Cells Transl Med. 2015;4:1265–74.
Dinh PC, Paudel D, Brochu H, Popowski KD, Gracieux MC, Cores J, et al. Inhalation of lung spheroid cell secretome and exosomes promotes lung restore in pulmonary fibrosis. Nat Commun. 2020;11:1064.
Alhomrani M, Correia J, Zavou M, Leaw B, Kuk N, Xu R, et al. The human amnion epithelial cell secretome decreases hepatic fibrosis in mice with persistent liver fibrosis. Entrance Pharmacol. 2017;8:748.
Moodley Y, Ilancheran S, Samuel C, Vaghjiani V, Atienza D, Williams ED, et al. Human amnion epithelial cell transplantation abrogates lung fibrosis and augments restore. Am J Respir Crit Care Med. 2010;182:643–51.
Tan JL, Lau SN, Leaw B, Nguyen HPT, Salamonsen LA, Saad MI, et al. Amnion epithelial cell-derived Exosomes Prohibit Lung Damage and improve endogenous lung restore. Stem Cells Transl Med. 2018;7:180–96.
Royce SG, Patel KP, Mao W, Zhu D, Lim R, Samuel CS. Serelaxin enhances the therapeutic results of human amnion epithelial cell-derived exosomes in experimental fashions of lung illness. Br J Pharmacol. 2019;176:2195–208.
Takahashi Ok, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and grownup fibroblast cultures by outlined components. Cell. 2006;126:663–76.
Jung JH, Ikeda G, Tada Y, von Bornstädt D, Santoso MR, Wahlquist C, et al. miR-106a-363 cluster in extracellular vesicles promotes endogenous myocardial restore by way of Notch3 pathway in ischemic coronary heart harm. Primary Res Cardiol. 2021;116:19.
Yamanaka S. Pluripotent stem cell-based Cell Remedy-Promise and Challenges. Cell Stem Cell. 2020;27:523–31.
Fujita Y, Kosaka N, Araya J, Kuwano Ok, Ochiya T. Extracellular vesicles in lung microenvironment and pathogenesis. Tendencies Mol Med. 2015;21:533–42.
Feng Z, Zhou J, Liu Y, Xia R, Li Q, Yan L, et al. Epithelium- and endothelium-derived exosomes regulate the alveolar macrophages by concentrating on RGS1 mediated calcium signaling-dependent immune response. Cell Dying Differ. 2021;28:2238–56.
Kadota T, Fujita Y, Araya J, Watanabe N, Fujimoto S, Kawamoto H, et al. Human bronchial epithelial cell-derived extracellular vesicle remedy for pulmonary fibrosis by way of inhibition of TGF-β-WNT crosstalk. J Extracell Vesicles. 2021;10:e12124.
Chen L, Charrier A, Zhou Y, Chen R, Yu B, Agarwal Ok, et al. Epigenetic regulation of connective tissue development issue by MicroRNA-214 supply in exosomes from mouse or human hepatic stellate cells. Hepatology. 2014;59:1118–29.
McCommis Ok, Hodges W, Brunt E, Nalbantoglu I, McDonald W, Holley C, et al. Focusing on the mitochondrial pyruvate service attenuates fibrosis in a mouse mannequin of nonalcoholic steatohepatitis. Hepatology. 2017;65:1543–56.
Hou X, Yin S, Ren R, Liu S, Yong L, Liu Y, et al. Myeloid-cell-specific IL-6 signaling promotes MicroRNA-223-Enriched Exosome manufacturing to Attenuate NAFLD-Related Fibrosis. Hepatology. 2021;74:116–32.
Chen L, Chen R, Kemper S, Cong M, You H, Brigstock DR. Therapeutic results of serum extracellular vesicles in liver fibrosis. J Extracell Vesicles. 2018;7:1461505.
Solar A, Lai Z, Zhao M, Mu L, Hu X. Native nanodiscs from blood inhibit pulmonary fibrosis. Biomaterials. 2019;192:51–61.
Chen S, Solar F, Qian H, Xu W, Jiang J. Preconditioning and Engineering Methods for Enhancing the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cell-Free Remedy. Stem Cells Int. 2022; 2022:1779346.
Pulido-Escribano V, Torrecillas-Baena B, Camacho-Cardenosa M, Dorado G, G?lvez-Moreno M?, Casado-D?az A. Function of hypoxia preconditioning in therapeutic potential of mesenchymal stem-cell-derived extracellular vesicles World Journal of Stem Cells 2022;14(7):453–472. https://doi.org/10.4252/wjsc.v14.i7.453.
Zhu J, Lu Ok, Zhang N, Zhao Y, Ma Q, Shen J, et al. Myocardial reparative features of exosomes from mesenchymal stem cells are enhanced by hypoxia therapy of the cells by way of transferring microRNA-210 in an nSMase2-dependent method. Artif Cells Nanomed Biotechnol. 2018;46:1659–70.
Tolomeo AM, Castagliuolo I, Piccoli M, Grassi M, Magarotto F, De Lazzari G, et al. Extracellular vesicles secreted by mesenchymal stromal cells exert Reverse Results to their cells of Origin in Murine Sodium Dextran Sulfate-Induced Colitis. Entrance Immunol. 2021;12:627605.
Liang YC, Wu YP, Li XD, Chen SH, Ye XJ, Xue XY, et al. TNF-α-induced exosomal miR-146a mediates mesenchymal stem cell-dependent suppression of urethral stricture. J Cell Physiol. 2019;234:23243–55.
Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for focused drug supply. Theranostics. 2021;11:3183–95.
Piffoux M, Volatron J, Cherukula Ok, Aubertin Ok, Wilhelm C, Silva AKA, et al. Engineering and loading therapeutic extracellular vesicles for scientific translation: a knowledge reporting body for comparability. Adv Drug Supply Rev. 2021;178:113972.
Yim N, Ryu SW, Choi Ok, Lee KR, Lee S, Choi H, et al. Exosome engineering for environment friendly intracellular supply of soluble proteins utilizing optically reversible protein-protein interplay module. Nat Commun. 2016;7:12277.
Hung ME, Leonard JN. A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated supply. J Extracell Vesicles. 2016;5:31027.
Chen L, Wang Y, Li S, Zuo B, Zhang X, Wang F, et al. Exosomes derived from GDNF-modified human adipose mesenchymal stem cells ameliorate peritubular capillary loss in tubulointerstitial fibrosis by activating the SIRT1/eNOS signaling pathway. Theranostics. 2020;10:9425–42.
Qu Y, Zhang Q, Cai X, Li F, Ma Z, Xu M, et al. Exosomes derived from mir-181-5p-modified adipose-derived mesenchymal stem cells stop liver fibrosis by way of autophagy activation. J Cell Mol Med. 2017;21:2491–502.
Villamizar O, Waters SA, Scott T, Grepo N, Jaffe A. Morris KV. Mesenchymal stem cell exosome delivered Zinc Finger protein activation of cystic fibrosis transmembrane conductance regulator. J Extracell Vesicles. 2021;10:e12053.
Wang H, Wang B, Zhang A, Hassounah F, Seow Y, Wooden M, et al. Exosome-mediated miR-29 switch reduces muscle atrophy and kidney fibrosis in mice. Mol Ther. 2019;27:571–83.
Salunkhe S, Dheeraj, Basak M, Chitkara D, Mittal A. Floor functionalization of exosomes for target-specific supply and in vivo imaging & monitoring: methods and significance. J Managed Launch. 2020;326:599–614.
You DG, Oh BH, Nguyen VQ, Lim GT, Um W, Jung JM, et al. Vitamin A-coupled stem cell-derived extracellular vesicles regulate the fibrotic cascade by concentrating on activated hepatic stellate cells in vivo. J Managed Launch. 2021;336:285–95.
Solar L, Fan M, Huang D, Li B, Xu R, Gao F, et al. Clodronate-loaded liposomal and fibroblast-derived exosomal hybrid system for enhanced drug supply to pulmonary fibrosis. Biomaterials. 2021;271:120761.
Zhang J, Ji C, Zhang H, Shi H, Mao F, Qian H, et al. Engineered neutrophil-derived exosome-like vesicles for focused most cancers remedy. Sci Adv. 2022;8:eabj8207.
Lee JR, Park BW, Kim J, Choo YW, Kim HY, Yoon JK, et al. Nanovesicles derived from iron oxide nanoparticles-incorporated mesenchymal stem cells for cardiac restore. Sci Adv. 2020;6:eaaz0952.
Ju Y, Hu Y, Yang P, Xie X, Fang B. Extracellular vesicle-loaded hydrogels for tissue restore and regeneration. Mater At this time Bio. 2023;18:100522.
Silva A, Perretta S, Perrod G, Pidial L, Lindner V, Carn F, et al. Thermoresponsive Gel embedded with adipose stem-cell-derived extracellular vesicles promotes esophageal Fistula Therapeutic in a Thermo-Actuated Supply Technique. ACS Nano. 2018;12:9800–14.
Berger A, Araújo-Filho I, Piffoux M, Nicolás-Boluda A, Grangier A, Boucenna I, et al. Native administration of stem cell-derived extracellular vesicles in a thermoresponsive hydrogel promotes a pro-healing impact in a rat mannequin of colo-cutaneous post-surgical fistula. Nanoscale. 2021;13:218–32.
Fu P, Zhang J, Li H, Mak M, Xu W, Tao Z. Extracellular vesicles as supply programs at nano-/micro-scale. Adv Drug Deliv Rev. 2021;179:113910.
Wiklander OPB, Nordin JZ, O’Loughlin A, Gustafsson Y, Corso G, Mäger I, et al. Extracellular vesicle in vivo biodistribution is set by cell supply, route of administration and concentrating on. J Extracell Vesicles. 2015;4:26316.
van Niel G, Carter DRF, Clayton A, Lambert DW, Raposo G, Vader P. Challenges and instructions in finding out cell-cell communication by extracellular vesicles. Nat Rev Mol Cell Biol. 2022;23:369–82.
Ramirez MI, Amorim MG, Gadelha C, Milic I, Welsh JA, Freitas VM, et al. Technical challenges of working with extracellular vesicles. Nanoscale. 2018;10:881–906.
Veerman RE, Teeuwen L, Czarnewski P, Güclüler Akpinar G, Sandberg A, Cao X, et al. Molecular analysis of 5 completely different isolation strategies for extracellular vesicles reveals completely different scientific applicability and subcellular origin. J Extracell Vesicles. 2021;10:e12128.
Doyle L, Wang M. Overview of Extracellular Vesicles, Their Origin, Composition, Objective, and Strategies for Exosome Isolation and Evaluation. Cells. 2019; 8.
Liang Y, Lehrich BM, Zheng S, Lu M. Rising strategies in biomarker identification for extracellular vesicle-based liquid biopsy. J Extracell Vesicles. 2021;10:e12090.
Barteneva NS, Fasler-Kan E, Bernimoulin M, Stern JN, Ponomarev ED, Duckett L, et al. Circulating microparticles: sq. the circle. BMC Cell Biol. 2013;14:23.
Wu P, Zhang B, Ocansey D, Xu W, Qian H. Extracellular vesicles: a vibrant star of nanomedicine. Biomaterials. 2021;269:120467.
Soekmadji C, Li B, Huang Y, Wang H, An T, Liu C, et al. The way forward for Extracellular vesicles as Theranostics – an ISEV assembly report. J Extracell Vesicles. 2020;9:1809766.
